These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36332769)

  • 1. Anticholinergic Medications and Parent-Reported Anticholinergic Symptoms in Neurologically Impaired Children.
    Feinstein JA; Feudtner C; Kempe A; Orth LE
    J Pain Symptom Manage; 2023 Feb; 65(2):e109-e114. PubMed ID: 36332769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
    Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
    Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
    Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
    J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Targets for Deprescribing in Medically Complex Older Adults with Suspected Cognitive Impairment.
    Pavon JM; Berkowitz TSZ; Smith VA; Hughes JM; Hung A; Hastings SN
    Geriatrics (Basel); 2022 May; 7(3):. PubMed ID: 35645282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
    Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS
    Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Older adults' exposure to anticholinergic medications: Implications for pharmaceutical care for Nigerian older adults.
    Okoro RN; Idris AI
    J Med Access; 2022; 6():27550834221112753. PubMed ID: 36204529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticholinergic burden in older adults with psychiatric illnesses: A cross-sectional study.
    Chahine B; Al Souheil F; Yaghi G
    Arch Psychiatr Nurs; 2023 Jun; 44():26-34. PubMed ID: 37197858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disentangling drug contributions: anticholinergic burden in older adults linked to individual medications: a cross-sectional population-based study.
    Bhatkhande G; Choudhry NK; Mahesri M; Haff N; Lauffenburger JC
    BMC Geriatr; 2024 Jan; 24(1):44. PubMed ID: 38200457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticholinergic medications: an additional contributor to cognitive impairment in the heart failure population?
    Shaukat A; Habib A; Lane KA; Shen C; Khan S; Hellman YM; Boustani M; Malik AS
    Drugs Aging; 2014 Oct; 31(10):749-54. PubMed ID: 25142050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study.
    Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM
    Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation Between Delirium and Anticholinergic Drug Burden in a Cohort of Hospitalized Older Patients: An Observational Study.
    Pasina L; Colzani L; Cortesi L; Tettamanti M; Zambon A; Nobili A; Mazzone A; Mazzola P; Annoni G; Bellelli G
    Drugs Aging; 2019 Jan; 36(1):85-91. PubMed ID: 30484239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic Burden of Geriatric Ward Inpatients.
    Wilczyński K; Gorczyca M; Gołębiowska J; Szewieczek J
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684152
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population -Differences between Four Anticholinergic Scales].
    Kimura T; Kato D; Nishimura T; Van Schyndle J; Uno S; Yoshida M
    Yakugaku Zasshi; 2020; 140(5):701-710. PubMed ID: 32378674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia.
    Joshi YB; Thomas ML; Braff DL; Green MF; Gur RC; Gur RE; Nuechterlein KH; Stone WS; Greenwood TA; Lazzeroni LC; MacDonald LR; Molina JL; Nungaray JA; Radant AD; Silverman JM; Sprock J; Sugar CA; Tsuang DW; Tsuang MT; Turetsky BI; Swerdlow NR; Light GA
    Am J Psychiatry; 2021 Sep; 178(9):838-847. PubMed ID: 33985348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission.
    Sevilla-Sánchez D; Molist-Brunet N; González-Bueno J; Solà-Bonada N; Espaulella-Panicot J; Codina-Jané C
    Geriatr Gerontol Int; 2018 Aug; 18(8):1159-1165. PubMed ID: 29644803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline anticholinergic burden from medications predicts poorer baseline and long-term health-related quality of life in 16 675 men and women of EPIC-Norfolk prospective population-based cohort study.
    Yrjana KR; Neal SR; Soiza RL; Keevil V; Luben RN; Wareham NJ; Khaw KT; Myint PK
    Pharmacoepidemiol Drug Saf; 2021 Feb; 30(2):135-143. PubMed ID: 32757254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticholinergic medications in community-dwelling older veterans: prevalence of anticholinergic symptoms, symptom burden, and adverse drug events.
    Ness J; Hoth A; Barnett MJ; Shorr RI; Kaboli PJ
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):42-51. PubMed ID: 16730620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticholinergic burden in older inpatients on psychotropic medication: do we care?
    Lee MS; Kisely S; Zolotarev B; Warren A; Henderson J; George M
    Australas Psychiatry; 2017 Dec; 25(6):566-570. PubMed ID: 28868891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic Medication Burden in Parkinson's Disease Outpatients.
    Nawaz H; Sargent L; Quilon H; Cloud LJ; Testa CM; Snider JD; Lageman SK; Baron MS; Berman BD; Zimmerman K; Price ET; Mukhopadhyay ND; Barrett MJ
    J Parkinsons Dis; 2022; 12(2):599-606. PubMed ID: 34806617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
    Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.